Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Hepatitis C

Free Subscription 15.08.2022 1 Ann Intern Med 1 Clin Res Hepatol Gastroenterol 1 Hepatology 1 J Infect Dis 1 J Viral Hepat 1 PLoS One 1 Transplant Proc

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Intern Med

1. GREBELY J, Dore GJ, Altice FL, Conway B, et al
   Reinfection and Risk Behaviors After Treatment of Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy : A Cohort Study.
   Ann Intern Med. 2022 Aug 9. doi: 10.7326/M21-4119.
   PubMed         Abstract available
   
   

   
   Clin Res Hepatol Gastroenterol

2. CAROLE S, Elena L, Benedicte LV, Abdoul-Aziz D, et al
   Acute Myeloid Leukaemia following Direct Acting Antiviral drugs in HCV-infected patients: a 10 years' retrospective single-center study.
   Clin Res Hepatol Gastroenterol. 2022 Aug 3:102000.
   PubMed         Abstract available
   
   

   
   Hepatology

3. TRUDEAU S, Mendiratta V, Dababneh Y, Hollingsworth J, et al
   Letter to the Editor: Successful treatment of multidrug resistant hepatitis C after >12 months of continuous therapy with direct-acting antivirals.
   Hepatology. 2022 Jul 27. doi: 10.1002/hep.32688.
   PubMed        
   
   

   
   J Infect Dis

4. GARDNER AR, Ma Y, Bacchetti P, Price JC, et al
   Longitudinal Assessment of the Enhanced Liver Fibrosis Score in the Era of Contemporary HIV and Hepatitis C Virus Treatment.
   J Infect Dis. 2022 Aug 11. pii: 6650396. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Viral Hepat

5. ROBINS A, Dolman G, Williams S, Gelson W, et al
   Hepatitis E Case Series. A UK Experience.
   J Viral Hepat. 2022 Jun 2. doi: 10.1111/jvh.13714.
   PubMed         Abstract available
   
   

   
   PLoS One

6. SCHORR O, Blach S, Thurnheer C, Ruis C, et al
   Modelling the microelimination of chronic hepatitis C in the canton of Bern, Switzerland: Reaching the Swiss Hepatitis Strategy goals despite the impact of the COVID 19 pandemic.
   PLoS One. 2022;17:e0272518.
   PubMed         Abstract available
   
   

   
   Transplant Proc

7. OKUMURA K, Sogawa H, Samson D, Butler J, et al
   Improving Liver Transplant Outcomes for Hepatitis C Virus Hepatocellular Carcinoma in the Direct-Acting Antiviral Therapy Era.
   Transplant Proc. 2022 Aug 4. pii: S0041-1345(22)00445.
   PubMed         Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis C is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: